4 ms·
Most countries have already had SARS-2 work its way through them significantly. The utility of a vaccine might be lower than you think. NZ comes to mind as a c
by __blockcipher__ 6y ago
Most countries have already had SARS-2 work its way through them significantly. The utility of a vaccine might be lower than you think.
NZ comes to mind as a country that has barely built up any immunity (due to them trying to contain it completely). They can expect more utility from a vaccine than otherwise.
Anyway, given the incredibly low rate of both mortality and also any real consequences in, say, those under age 55, their personal benefit of a vaccine is incredibly low. So it really comes down to whether you’re a Sweden person or a New Zealand person.
I’m a Sweden person personally.
- orra 6y ago> Most countries have already had SARS-2 work its way through them significantly. Noope, that isn’t what antibody testing shows. Take England for example. Coronavirus working its way through a mere, say, 6% of the population is devastating. > The utility of a vaccine might be lower than you think. Nonsense. We need to protect the other 94%.
- ketamine__ 6y agoYou're referring to antibody testing? Is any T-cell testing being done?
- lbeltrame 6y agoThe problem with aggregate numbers like that 6% is that they assume a uniform distribution of the virus within the population, which is not the case: some areas are far more hit than others. I think this should always be kept into account.
- orra 6y agoYeah, in major population centres like London, about 20% of people caught it. Whereas rural England will be lower than that 6% average. That’s the areas. As for age or demographics of people who caught it in England, I don’t think that is well known.
- harambae 6y ago>The utility of a vaccine might be lower than you think. Especially given that most Americans won't take it [0]. [0] https://www.axios.com/covid-vaccine-election-f267a641-a19f-43e0-80a0-87c8e6eb303f.html https://www.axios.com/covid-vaccine-election-f267a641-a19f-4...